Baker Brothers Advisors - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 150 filers reported holding KURA ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.5%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q1 2022$4,413,000
+3.6%
274,458
-9.8%
0.02%
+19.0%
Q4 2021$4,258,000
-25.3%
304,1580.0%0.02%
-16.0%
Q3 2021$5,697,000304,1580.02%
Other shareholders
KURA ONCOLOGY INC shareholders Q2 2022
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,849,947$34,650,0005.10%
COMMODORE CAPITAL LP 999,433$18,719,0004.94%
Affinity Asset Advisors, LLC 530,000$9,927,0002.51%
EcoR1 Capital, LLC 3,724,437$69,759,0002.43%
Ghost Tree Capital, LLC 425,000$7,960,0002.33%
Asymmetry Capital Management, L.P. 194,309$3,639,0002.19%
ACUTA CAPITAL PARTNERS, LLC 291,884$5,467,0001.93%
Sio Capital Management, LLC 228,318$4,276,0001.36%
SPHERA FUNDS MANAGEMENT LTD. 788,735$14,773,0001.24%
BVF INC/IL 1,635,112$30,626,0001.20%
View complete list of KURA ONCOLOGY INC shareholders